Literature DB >> 20461286

Preparation of a working seed lot of BCG and quality control by PCR genotyping.

A Trovero1, C Argüelles, A Cataldi.   

Abstract

The bacillus Calmette-Guérin (BCG) was obtained in 1920 after successive passages leading to the attenuation of a Mycobacterium bovis strain. For the following 40 years, BCG had been replicated, resulting in substrains with genotypic and phenotypic differences. Several genomic studies have compared two BCG strains, M. bovis and Mycobacterium tuberculosis, and observed that deleted regions in the different strains could be related to differences in antigenic properties. In this work, a working seed lot was obtained from a lyophilized secondary seed lot from the BCG Pasteur strain 1173 P2 and genetically characterized. The genome was analyzed by PCR directed to five regions (RD1, RD2, RD14, RD15, DU2), using the seed lot and different available strains as templates. No genetic differences were found in the fragments studied as compared to the Pasteur strain. A total of 20 passages were carried out and no differences were found in the size of the fragments amplified by PCR. In conclusion, this method allows to control a working seed lot genotypically and to assess the stability of the BCG genome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461286     DOI: 10.1590/S0325-75412010000100002

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  3 in total

1.  Thr270Ile in embC (Rv3793) is not a marker for ethambutol resistance in the Mycobacterium tuberculosis complex.

Authors:  Claudio U Köser; David K Summers; John A C Archer
Journal:  Antimicrob Agents Chemother       Date:  2011-04       Impact factor: 5.191

2.  Pathogenic Effects of M. tuberculosis-Specific Proteins ESAT-6 and CFP-10 in Macrophage Culture and in 3D-Granulemogenesis Model In Vitro.

Authors:  S N Belogorodtsev; E K Nemkova; N V Stavitskaya; Ya Sh Schwartz
Journal:  Bull Exp Biol Med       Date:  2021-10-07       Impact factor: 0.804

3.  Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.

Authors:  Narcís Saubi; Alice Mbewe-Mvula; Ester Gea-Mallorqui; Maximillian Rosario; Josep Maria Gatell; Tomáš Hanke; Joan Joseph
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.